Assessment of major gaps

Dec 19, 2019

Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.

Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.

Recent News

New Neuroendocrine Cancer UK Ambassador

New Neuroendocrine Cancer UK Ambassador

Please join us in welcoming our newest Ambassador, Ashley to the team 🦋     Where to begin! I know most people that have neuroendocrine cancer can relate as our story’s can be long.   From 2012 I had ongoing issues with my stomach from pain after eating,...

read more
Neuroendocrine Cancer patient experience survey

Neuroendocrine Cancer patient experience survey

All Neuroendocrine Cancer patients globally are invited to share their experiences and perspectives on how treatment decisions have been modified during the COVID-19 pandemic for them via a specially designed survey. The survey is available in English, French, Italian...

read more